Literature DB >> 2138476

Percoll density gradient centrifugation of rat pituitary tumor cells: a study of functional heterogeneity within and between tumors with respect to growth rates, prolactin production and responsiveness to the somatostatin analog SMS 201-995.

L J Hofland1, P M van Koetsveld, S W Lamberts.   

Abstract

UNLABELLED: Tumor cells prepared from PRL-secreting rat pituitary 7315b tumors of increasing weight were separated on continuous Percoll density gradients, according to differences in their density. Whether the cell subpopulations obtained by density gradient separation showed differences in protein content per cell, PRL production per cell, growth rates and responsiveness to the somatostatin analog SMS 201-995 in vitro was investigated. In addition, we studied PRL release by individual 7315b tumor cells, using the reverse hemolytic plaque assay (RHPA). The tumor cells from tumors of increasing weight were recovered within a narrow density range (1.060-1.070 g/ml) and showed a normal distribution profile. There were no differences between the subpopulations with respect to the parameters mentioned above. Moreover, no differences were found with respect to these parameters between tumor cells derived from tumors of increasing weight. In agreement with the above data we found no evidence for subtype of adenoma cells being preferentially responsive to SMS 201-995, using the RHPA.
CONCLUSIONS: (1) the transplantable PRL-secreting rat pituitary tumor 7315b consists of a functionally homogeneous cell population; (2) growth of this tumor in vivo does not lead to the induction of functionally heterogeneous cell subpopulations within this tumor; (3) the escape of this tumor from the tumor growth-inhibitory effect of SMS 201-995, which has previously been demonstrated in vivo, may not have been the result of clonal selection of somatostatin-unresponsive cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2138476     DOI: 10.1016/0277-5379(90)90254-q

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  15 in total

1.  Effects of Ketoconazole on ACTH-Producing and Non-ACTH-Producing Neuroendocrine Tumor Cells.

Authors:  Aura D Herrera-Martínez; Richard A Feelders; Wouter W de Herder; Justo P Castaño; María Ángeles Gálvez Moreno; Fadime Dogan; Rosanna van Dungen; Peter van Koetsveld; Leo J Hofland
Journal:  Horm Cancer       Date:  2019-05-18       Impact factor: 3.869

2.  Inhibition of Human Adrenocortical Cancer Cell Growth by Temozolomide in Vitro and the Role of the MGMT Gene.

Authors:  S G Creemers; P M van Koetsveld; E S R van den Dungen; E Korpershoek; F J van Kemenade; G J H Franssen; W W de Herder; R A Feelders; L J Hofland
Journal:  J Clin Endocrinol Metab       Date:  2016-09-07       Impact factor: 5.958

3.  Encephalitozoon intestinalis Infection Impacts the Expression of Apoptosis-Related Genes in U937 Macrophage Cells.

Authors:  Ülfet Çetinkaya; Armağan Caner; Arzuv Charyyeva; Meryem Şentürk; Meryem Eren
Journal:  Acta Parasitol       Date:  2020-10-09       Impact factor: 1.440

4.  Inflammatory cytokines stimulate the adhesion of colon carcinoma cells to mesothelial monolayers.

Authors:  W M U van Grevenstein; L J Hofland; M E E van Rossen; P M van Koetsveld; J Jeekel; C H J van Eijck
Journal:  Dig Dis Sci       Date:  2007-03-30       Impact factor: 3.199

5.  Type I interferons in the treatment of pancreatic cancer: mechanisms of action and role of related receptors.

Authors:  Giovanni Vitale; Casper H J van Eijck; Peter M van Koetsveld Ing; Joris I Erdmann; Ernst Jan M Speel; Katy van der Wansem Ing; Diana M Mooij; Annamaria Colao; Gaetano Lombardi; Ed Croze; Steven W J Lamberts; Leo J Hofland
Journal:  Ann Surg       Date:  2007-08       Impact factor: 12.969

6.  IFN-β is a potent inhibitor of insulin and insulin like growth factor stimulated proliferation and migration in human pancreatic cancer cells.

Authors:  Stephanie Booy; Casper Hj van Eijck; Joseph Amjl Janssen; Fadime Dogan; Peter M van Koetsveld; Leo J Hofland
Journal:  Am J Cancer Res       Date:  2015-05-15       Impact factor: 6.166

7.  The role of superoxide anions in the development of distant tumour recurrence.

Authors:  M ten Kate; J B C van der Wal; W Sluiter; L J Hofland; J Jeekel; P Sonneveld; C H J van Eijck
Journal:  Br J Cancer       Date:  2006-11-07       Impact factor: 7.640

8.  Somatostatin analogues for receptor targeted photodynamic therapy.

Authors:  Slávka Kaščáková; Leo J Hofland; Henriette S De Bruijn; Yunpeng Ye; Samuel Achilefu; Katy van der Wansem; Angelique van der Ploeg-van den Heuvel; Peter M van Koetsveld; Michael P Brugts; Aart-Jan van der Lelij; Henricus J C M Sterenborg; Timo L M Ten Hagen; Dominic J Robinson; Martin P van Hagen
Journal:  PLoS One       Date:  2014-08-11       Impact factor: 3.240

9.  Modifying Effects of Glucose and Insulin/Insulin-Like Growth Factors on Colon Cancer Cells.

Authors:  Şeyda Berk; Joseph A M J L Janssen; Peter M van Koetsveld; Fadime Dogan; Naci Değerli; Servet Özcan; Fahrettin Kelestimur; Leo J Hofland
Journal:  Front Oncol       Date:  2021-07-05       Impact factor: 6.244

10.  Influence of type-I Interferon receptor expression level on the response to type-I Interferons in human pancreatic cancer cells.

Authors:  Stephanie Booy; Casper H J van Eijck; Fadime Dogan; Peter M van Koetsveld; Leo J Hofland
Journal:  J Cell Mol Med       Date:  2014-01-25       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.